Jason M. Uslaner

3.8k total citations
77 papers, 2.6k citations indexed

About

Jason M. Uslaner is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Jason M. Uslaner has authored 77 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cellular and Molecular Neuroscience, 40 papers in Molecular Biology and 15 papers in Pharmacology. Recurrent topics in Jason M. Uslaner's work include Neuroscience and Neuropharmacology Research (32 papers), Receptor Mechanisms and Signaling (25 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). Jason M. Uslaner is often cited by papers focused on Neuroscience and Neuropharmacology Research (32 papers), Receptor Mechanisms and Signaling (25 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). Jason M. Uslaner collaborates with scholars based in United States, United Kingdom and Belgium. Jason M. Uslaner's co-authors include Terry E. Robinson, Joshua D. Vardigan, Sean M. Smith, Pete H. Hutson, Peter H. Hutson, John J. Renger, Scott D. Kuduk, Huda Akil, Stanley J. Watson and Heidi E.W. Day and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and NeuroImage.

In The Last Decade

Jason M. Uslaner

76 papers receiving 2.5k citations

Peers

Jason M. Uslaner

CMN

EAS

ECP

Michael Bubser United States

Valentina Vengeliene Germany

Leonard L. Howell United States

J. Tauscher Austria

Naoe Okamura Japan

Mostafa El Mansari Canada

Mauro Corsi Italy

Hugh Marston United Kingdom

Neil Upton United Kingdom

Dimitri De Bundel Belgium

Michael Bubser United States

Jason M. Uslaner

2.3k ×1.7

CMN

1.5k ×1.4

1.1k ×1.4

419 ×1.2

EAS

205 ×0.6

ECP

Citations per year, relative to Jason M. Uslaner Jason M. Uslaner (= 1×) peers Michael Bubser

Countries citing papers authored by Jason M. Uslaner

Since Specialization

Citations

This map shows the geographic impact of Jason M. Uslaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason M. Uslaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason M. Uslaner more than expected).

Fields of papers citing papers by Jason M. Uslaner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason M. Uslaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason M. Uslaner. The network helps show where Jason M. Uslaner may publish in the future.

Co-authorship network of co-authors of Jason M. Uslaner

This figure shows the co-authorship network connecting the top 25 collaborators of Jason M. Uslaner. A scholar is included among the top collaborators of Jason M. Uslaner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason M. Uslaner. Jason M. Uslaner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Breslin, Michael J., Deping Wang, Chien-Jung Huang, et al.. (2024). 2-Aminopyridines as Potent and Selective Na_v1.8 Inhibitors Exhibiting Efficacy in a Nonhuman Primate Pain Model. ACS Medicinal Chemistry Letters. 15(6). 917–923. 3 indexed citations

Layton, M. E., Jeffrey C. Kern, William D. Shipe, et al.. (2023). Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia. Journal of Medicinal Chemistry. 66(2). 1157–1171. 22 indexed citations

Tian, Yuan, Yi Wang, Yinghui Hu, et al.. (2021). Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology. Neurobiology of Disease. 161. 105548–105548. 13 indexed citations

Shu, Youheng, Tracy L. Diamond, James C. Hershey, et al.. (2020). Discovery of 4-arylquinoline-2-carboxamides, highly potent and selective class of mGluR2 negative allosteric modulators: From HTS to activity in animal models. Bioorganic & Medicinal Chemistry Letters. 30(9). 127066–127066. 4 indexed citations

Wang, Xiaohai, Ian M. Bell, & Jason M. Uslaner. (2020). Activators of α7 nAChR as Potential Therapeutics for Cognitive Impairment. Current topics in behavioral neurosciences. 45. 209–245. 7 indexed citations

Stachel, Shawn J., Melissa S. Egbertson, Jenny Wai, et al.. (2018). Indole acids as a novel PDE2 inhibitor chemotype that demonstrate pro-cognitive activity in multiple species. Bioorganic & Medicinal Chemistry Letters. 28(6). 1122–1126. 3 indexed citations

Stachel, Shawn J., Richard Berger, Daniel V. Paone, et al.. (2018). Structure-Guided Design and Procognitive Assessment of a Potent and Selective Phosphodiesterase 2A Inhibitor. ACS Medicinal Chemistry Letters. 9(8). 815–820. 13 indexed citations

Zhao, Fuqiang, Xiaohai Wang, Hatim A. Zariwala, et al.. (2017). fMRI study of the role of glutamate NMDA receptor in the olfactory adaptation in rats: Insights into cellular and molecular mechanisms of olfactory adaptation. NeuroImage. 149. 348–360. 13 indexed citations

Vardigan, Joshua D., Henry S. Lange, Spencer J. Tye, et al.. (2016). Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activity. Psychopharmacology. 233(13). 2441–2450. 3 indexed citations

10.

Zhao, Fuqiang, Xiaohai Wang, Hatim A. Zariwala, et al.. (2015). fMRI study of olfaction in the olfactory bulb and high olfactory structures of rats: Insight into their roles in habituation. NeuroImage. 127. 445–455. 23 indexed citations

11.

Gotter, Anthony L., Susan L. Garson, Joanne Stevens, et al.. (2014). Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators. BMC Neuroscience. 15(1). 109–109. 40 indexed citations

12.

Tannenbaum, Pamela L., Joanne Stevens, Alan T. Savitz, et al.. (2014). Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs. Frontiers in Behavioral Neuroscience. 8. 182–182. 32 indexed citations

13.

Eddins, Donnie, Terence G. Hamill, Christopher E. Cannon, et al.. (2013). The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey. Psychopharmacology. 231(3). 511–519. 27 indexed citations

14.

Smith, Sean M., Jason M. Uslaner, Christopher D. Cox, et al.. (2012). The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey. Neuropharmacology. 64. 215–223. 70 indexed citations

15.

Uslaner, Jason M., et al.. (2009). Combined administration of an mGlu2/3 receptor agonist and a 5-HT2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants. Psychopharmacology. 206(4). 641–651. 25 indexed citations

16.

Smith, Sean M., Jason M. Uslaner, Lihang Yao, et al.. (2008). The Behavioral and Neurochemical Effects of a Novel d-Amino Acid Oxidase Inhibitor Compound 8 [4 H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and d-Serine. Journal of Pharmacology and Experimental Therapeutics. 328(3). 921–930. 73 indexed citations

17.

Uslaner, Jason M., Martín J. Acerbo, Samantha Jones, & Terry E. Robinson. (2006). The attribution of incentive salience to a stimulus that signals an intravenous injection of cocaine. Behavioural Brain Research. 169(2). 320–324. 94 indexed citations

18.

Uslaner, Jason M. & Terry E. Robinson. (2006). Subthalamic nucleus lesions increase impulsive action and decrease impulsive choice − mediation by enhanced incentive motivation?. European Journal of Neuroscience. 24(8). 2345–2354. 100 indexed citations

19.

Uslaner, Jason M., et al.. (2005). Subthalamic Nucleus Lesions Enhance the Psychomotor-Activating, Incentive Motivational, and Neurobiological Effects of Cocaine. Journal of Neuroscience. 25(37). 8407–8415. 27 indexed citations

20.

Uslaner, Jason M., Camille S. Norton, Stanley J. Watson, Huda Akil, & Terry E. Robinson. (2003). Amphetamine‐induced c‐fosmRNA expression in the caudate‐putamen and subthalamic nucleus: interactions between dose, environment, and neuronal phenotype. Journal of Neurochemistry. 85(1). 105–114. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact